Abstract
Low-dose, long-term use of 14-membered macrolides is effective for treatment of patients with chronic airway inflammation such as diffuse panbronchiolitis or chronic rhinosinusitis. However, long-term use of macrolides can promote the growth of drug-resistant bacteria, and the development of anti-inflammatory macrolides that lack antibiotic effects is desirable. Previously, we developed EM900, a novel 12-membered erythromycin A derivative, which has potent anti-inflammatory and immunomodulatory activities and lacks any antibacterial activity. We examined the anti-inflammatory effects of EM900 on mucus secretion from airway epithelial cells. To examine the in vivo effects of EM900 on airway inflammation, we induced hypertrophic and metaplastic changes of goblet cells in rat nasal epithelium via intranasal instillation of lipopolysaccharides. In vitro effects of EM900 on airway epithelial cells were examined using cultured human airway epithelial (NCI-H292) cells. Mucus secretion was evaluated via enzyme-linked immunosorbent assays with an anti-MUC5AC monoclonal antibody. Oral administration of EM900 or clarithromycin (CAM) significantly inhibited LPS-induced mucus production from rat nasal epithelium. EM900, CAM, or erythromycin...Continue Reading
References
Feb 1, 1991·The Journal of Antimicrobial Chemotherapy·F FraschiniG Demartini
Jun 1, 1995·Internal Medicine·T ShiraiK Chida
Jul 1, 1994·The European Respiratory Journal·D HoneybourneR Wise
Apr 1, 1996·American Journal of Respiratory and Critical Care Medicine·T ShimizuY Sakakura
Jun 25, 1998·American Journal of Respiratory and Critical Care Medicine·S KudohM Ando
Jan 19, 1999·Journal of Chromatography. B, Biomedical Sciences and Applications·J Sastre Toraño, H J Guchelaar
Mar 24, 1999·American Journal of Rhinology·C KishiokaY Sakakura
Jun 27, 2000·European Archives of Oto-rhino-laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery·K FujitaY Sakakura
Jul 11, 2000·American Journal of Rhinology·T YamadaH Saito
Jun 28, 2003·American Journal of Respiratory and Critical Care Medicine·Takeshi ShimizuYuichi Majima
Jul 10, 2003·Cytokine·M ErmertL Ermert
Feb 4, 2005·The Laryngoscope·Muneki HotomiNoboru Yamanaka
Apr 9, 2005·The Journal of Antibiotics·Kiminari YoshidaSatoshi Omura
Nov 12, 2005·The Journal of Antimicrobial Chemotherapy·David FelminghamReuben N Grüneberg
Jun 15, 2007·The Journal of Infection·David FelminghamStephen G Jenkins
Mar 12, 2011·The Journal of Antimicrobial Chemotherapy·Yun CaiYouning Liu
Apr 29, 2011·Bioorganic & Medicinal Chemistry Letters·Akihiro SugawaraToshiaki Sunazuka
Jun 4, 2011·Auris, Nasus, Larynx·Yuichi MajimaHiroshi Moriyama
Jul 21, 2011·Journal of Biomedicine & Biotechnology·Dong-Hyun KimSang Won Yeo
Nov 26, 2011·Pharmacology·Kazuya OtsuKazuhiko Takeuchi
May 12, 2012·Mediators of Inflammation·Takeshi Shimizu, Shino Shimizu
Jul 5, 2012·The Journal of Antibiotics·Akihiro SugawaraToshiaki Sunazuka
Citations
Oct 7, 2015·Auris, Nasus, Larynx·Takeshi Shimizu, Harumi Suzaki
Dec 30, 2016·Therapeutic Advances in Respiratory Disease·Shilin Qiu, Xiaoning Zhong
Jul 6, 2017·Allergy, Asthma & Immunology Research·Sung Woo Cho, Dong Young Kim
Jun 28, 2017·Antimicrobial Agents and Chemotherapy·Gopinath KasettyArne Egesten
Nov 23, 2018·Journal of Nippon Medical School = Nippon Ika Daigaku Zasshi·Nozomu WakayamaSatoshi Ōmura
Dec 11, 2019·Inflammation Research : Official Journal of the European Histamine Research Society ... [et Al.]·Hironori SadamatsuNaoko Sueoka-Aragane
Feb 27, 2017·BMC Pharmacology & Toxicology·Kuninori IwayamaNobumasa Hayase
Aug 3, 2019·The Veterinary Record·Sophie Mainguy-SeersJean-Pierre Lavoie
Jun 14, 2021·Pediatric Research·Jialiang Sun, Yanan Li
Sep 4, 2019·Respiration; International Review of Thoracic Diseases·Stephan F van Eeden, James C Hogg